The expanding indications for ICD therapy and the complexity of current devices will have impact on follow-up policy. The application of ICD therapy requires elaborate attention to technical aspects, arrhythmias, and the clinical course of the underlying disease. Currently, the quality of medical supervision is dependent on scheduled regular follow-up visits. A disadvantage of long intervals can be a delay in the physician's or patient's awareness of changes in the clinical status. Some patients will need more intensive follow-up while others will have the device as a stand-by and only need technical follow-up. A possibility to address this situation, is the transmission of data, already stored in the implanted device. This will guarantee continuous patient surveillance and could possibly help to avoid unnecessary follow-up visits.

, ,
doi.org/10.1053/eupc.2002.0302, hdl.handle.net/1765/72408
Europace
Department of Cardiology

Theuns, D., Res, J., & Jordaens, L. (2003). Home monitoring in ICD therapy: Future perspectives. Europace, 5(2), 139–142. doi:10.1053/eupc.2002.0302